JP2024527879A5 - - Google Patents
Info
- Publication number
- JP2024527879A5 JP2024527879A5 JP2024503984A JP2024503984A JP2024527879A5 JP 2024527879 A5 JP2024527879 A5 JP 2024527879A5 JP 2024503984 A JP2024503984 A JP 2024503984A JP 2024503984 A JP2024503984 A JP 2024503984A JP 2024527879 A5 JP2024527879 A5 JP 2024527879A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163225281P | 2021-07-23 | 2021-07-23 | |
| US63/225,281 | 2021-07-23 | ||
| US202263310526P | 2022-02-15 | 2022-02-15 | |
| US63/310,526 | 2022-02-15 | ||
| US202263344931P | 2022-05-23 | 2022-05-23 | |
| US63/344,931 | 2022-05-23 | ||
| PCT/US2022/074062 WO2023004425A2 (en) | 2021-07-23 | 2022-07-22 | Cd3-expressing natural killer cells with enhanced function for adoptive immunotherapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024527879A JP2024527879A (ja) | 2024-07-26 |
| JPWO2023004425A5 JPWO2023004425A5 (https=) | 2025-07-29 |
| JP2024527879A5 true JP2024527879A5 (https=) | 2025-07-29 |
Family
ID=84978775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024503984A Pending JP2024527879A (ja) | 2021-07-23 | 2022-07-22 | 養子免疫療法のための機能が強化されたｃｄ３発現ナチュラルキラー細胞 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240325443A1 (https=) |
| EP (1) | EP4373501A4 (https=) |
| JP (1) | JP2024527879A (https=) |
| KR (1) | KR20240041964A (https=) |
| AU (1) | AU2022315301A1 (https=) |
| CA (1) | CA3227317A1 (https=) |
| IL (1) | IL310307A (https=) |
| MX (1) | MX2024001073A (https=) |
| WO (1) | WO2023004425A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020232691B2 (en) | 2019-03-05 | 2023-06-29 | Nkarta, Inc. | CD19-directed chimeric antigen receptors and uses thereof in immunotherapy |
| AU2024244976A1 (en) * | 2023-03-24 | 2025-09-25 | Board Of Regents, The University Of Texas System | Engineered natural killer cells with enhanced antitumor memory responses |
| AU2024269870A1 (en) * | 2023-05-05 | 2025-11-20 | Board Of Regents, The University Of Texas System | Multi-receptor natural killer cells |
| KR20260024372A (ko) * | 2023-05-05 | 2026-02-20 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 다중-수용체 자연 살해 세포 |
| WO2026077446A1 (en) * | 2024-10-12 | 2026-04-16 | Nanjing Legend Biotech Co., Ltd. | Engineered il-15 constructs and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2854233C (en) * | 2011-11-04 | 2020-05-12 | Zymeworks Inc. | Stable heterodimeric antibody design with mutations in the fc domain |
| WO2016054520A2 (en) * | 2014-10-03 | 2016-04-07 | The California Institute For Biomedical Research | Engineered cell surface proteins and uses thereof |
| EP3331913A1 (en) * | 2015-08-07 | 2018-06-13 | Novartis AG | Treatment of cancer using chimeric cd3 receptor proteins |
| WO2017192536A1 (en) * | 2016-05-02 | 2017-11-09 | University Of Kansas | Eliminating mhc restriction from the t cell receptor as a strategy for immunotherapy |
| US11752172B2 (en) * | 2017-01-04 | 2023-09-12 | Nova Southeastern University | Natural killer (NK) cells expressing an antigen-specific functional T cell receptor (TCR) complex, methods for production thereof, and methods for therapeutic use thereof |
| WO2019071009A2 (en) * | 2017-10-05 | 2019-04-11 | Nantcell, Inc. | LIPID ANTIGENS AND L-CELL RECEPTORS ON NK CELLS |
| CN109777778B (zh) * | 2017-11-14 | 2023-07-18 | 中国科学院广州生物医药与健康研究院 | 一种基因改造的γδT细胞 |
| WO2020205359A1 (en) * | 2019-03-29 | 2020-10-08 | Board Of Regents, The University Of Texas System | Methods for production of car-nk cells and use thereof |
| EP3750547A1 (en) * | 2019-06-13 | 2020-12-16 | Universitätsmedizin der Johannes Gutenberg-Universität Mainz | Modified nk-92 cells, and therapeutic and diagnostic uses thereof |
| EP4003374A4 (en) * | 2019-07-23 | 2023-08-30 | Wen Yang | COMPOSITION AND METHODS OF ADOPTIVE IMMUNOTHERAPY |
-
2022
- 2022-07-22 IL IL310307A patent/IL310307A/en unknown
- 2022-07-22 EP EP22846863.3A patent/EP4373501A4/en active Pending
- 2022-07-22 KR KR1020247006166A patent/KR20240041964A/ko active Pending
- 2022-07-22 US US18/290,898 patent/US20240325443A1/en active Pending
- 2022-07-22 AU AU2022315301A patent/AU2022315301A1/en active Pending
- 2022-07-22 CA CA3227317A patent/CA3227317A1/en active Pending
- 2022-07-22 JP JP2024503984A patent/JP2024527879A/ja active Pending
- 2022-07-22 WO PCT/US2022/074062 patent/WO2023004425A2/en not_active Ceased
- 2022-07-22 MX MX2024001073A patent/MX2024001073A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024527879A5 (https=) | ||
| CL2025004171A1 (es) | Proceso para la fabricación de elementos protectores para celdas de electrolisis de agua alcalina | |
| CL2025003708S1 (es) | Rampa para maniobras vehiculares. | |
| BR102022026909A2 (https=) | ||
| BY13159U (https=) | ||
| BY13161U (https=) | ||
| CN307048454S (https=) | ||
| CN307048028S (https=) | ||
| CN307047893S (https=) | ||
| CN307047787S (https=) | ||
| CN307047184S (https=) | ||
| CN307046201S (https=) | ||
| CN307046094S (https=) | ||
| CN307045782S (https=) | ||
| CN307045709S (https=) | ||
| CN307045285S (https=) | ||
| CN307044988S (https=) | ||
| CN307044985S (https=) | ||
| CN307044816S (https=) | ||
| CN307044473S (https=) | ||
| BY23986C1 (https=) | ||
| BY23963C1 (https=) | ||
| BY13176U (https=) | ||
| BY13175U (https=) | ||
| BY13174U (https=) |